Middle East Conflict

Showing 916 articles
Business

AbCellera Biologics: A Tale of Two Valuations Amid Steep Share Decline

Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.

Business

ManpowerGroup Sees 'Stabilization' in Q4 as Demand Firms, Cost Cuts Take Hold

ManpowerGroup reported a return to modest organic growth in its fourth quarter, with executives citing improving demand and the benefits of ongoing cost optimization. While stopping short of declaring a broad recovery, the staffing giant highlighted sequential improvements in key markets and pointed to AI-driven productivity tools as a key differentiator.

Business

Olin Corporation: A Tale of Two Valuations as Stock Sends Mixed Signals

Olin Corporation's (NYSE: OLN) stock performance tells a conflicting story: a recent monthly gain contrasts sharply with steep multi-year declines. A deep dive into the numbers reveals a stark divide between cash flow-based and earnings-based valuation models, leaving investors to question where true value lies in the volatile chemicals sector.

Business

Clearway Energy's Valuation Puzzle: DCF Model Signals Deep Discount, But P/E Ratio Tells a Different Story

Shares of renewable energy producer Clearway Energy have delivered strong long-term gains, but recent trading has been mixed. A deep dive into its valuation reveals a stark contradiction: a discounted cash flow model suggests the stock is significantly undervalued, while its price-to-earnings multiple appears rich compared to a proprietary fair ratio. Investors are left weighing which metric paints the truer picture.

Business

Three Asian Penny Stocks Defying Market Headwinds in 2026

Amidst a backdrop of stable rates and cautious optimism, a handful of low-priced Asian equities are drawing investor scrutiny for their resilience and strategic positioning. We analyze three such companies navigating property downturns, infrastructure demand, and consumer shifts.